Robert Kaplan, the former CEO and president of the Federal Reserve Bank of Dallas, joined Star Mountain Capital, a specialized private credit and secondaries investment firm, as a senior advisor.

Kaplan has more than 40 years of investment management, business management, monetary policy, investment banking and leadership experience. In addition to serving as CEO and president of the Federal Reserve Bank of Dallas, Kaplan’s other previous roles include vice chairman of investment banking and investment management divisions of Goldman Sachs and professor and senior associate dean of Harvard Business School. Kaplan was also interim CEO and board member of the Harvard Management Company, chair of the investment advisory committee of Google, member of the investment committee and trustee of the Ford Foundation, and board member of State Street.

“We are honored to have Rob join Star Mountain as an aligned senior advisor bringing extensive investment, strategic leadership, business management and governance experience,” Brett Hickey, founder and CEO of Star Mountain Capital, said. “Having met Rob in 2009 as a student of his at Harvard Business School where I attended a CEO leadership program, it is a gratifying reflection and we are excited for the future where Rob can also have an impact in building leadership best practices with our portfolio companies.”

“There are many needs and opportunities to support established, growing private businesses, which is something I am excited to support,” Kaplan said. “It is a pleasure to join friends and former colleagues as part of Star Mountain’s team. The firm’s core values including alignment with investors and with each other was an important consideration for me.”

Kaplan currently serves as co-chairman of the Draper Richards Kaplan Foundation, a global venture philanthropy firm that invests in developing nonprofit enterprises dedicated to addressing social issues. He is a member of the advisory council of the George W. Bush Institute, an advisory board member of the Baker Institute and a board member of Harvard Medical School and serves as chairman of Project ALS.